---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/246193307.md"
description: "The biopharmaceutical sector continues to adjust, with *ST Four Rings hitting the daily limit down, Rongchang Bio falling over 18%, and Mabwell, SDKX, Science Sun Pharm, OPM, Aidea Pharma, and others following suit"
datetime: "2025-06-26T06:17:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/246193307.md)
  - [en](https://longbridge.com/en/news/246193307.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/246193307.md)
---

# 

The biopharmaceutical sector continues to adjust, \*ST SiHuan hit the daily limit down, Rongchang Bio fell over 18%, Mabwell, SDKX, Science Sun Pharm, OPM, Aidea Pharma, and others followed suit

### Related Stocks

- [688293.CN](https://longbridge.com/en/quote/688293.CN.md)
- [688488.CN](https://longbridge.com/en/quote/688488.CN.md)
- [300485.CN](https://longbridge.com/en/quote/300485.CN.md)
- [688062.CN](https://longbridge.com/en/quote/688062.CN.md)
- [688136.CN](https://longbridge.com/en/quote/688136.CN.md)
- [09995.HK](https://longbridge.com/en/quote/09995.HK.md)

## Related News & Research

- [PharmaTher selects PD Labs as US center of excellence for PERSONALIZ3D platform commercialization](https://longbridge.com/en/news/296225346.md)
- [CanSino’s Td5cp Booster Wins Priority Review After NDA Acceptance in China](https://longbridge.com/en/news/296020241.md)
- [13:22 ET/C O R R E C T I O N -- Rayence/](https://longbridge.com/en/news/296256530.md)
- [Morrisons sheds 5,000 jobs in turnaround push](https://longbridge.com/en/news/296126754.md)
- [BioNxt completes IMPD, moves toward first human bioequivalence trial for sublingual cladribine film in MS](https://longbridge.com/en/news/296314929.md)